CDKN1A and neoplasm: Despite its main characterization as a mediator of p53-dependent tumor suppressor activity several observations suggest an oncogenic potential of p21, presumably through its anti-apoptotic function and its ability to promote the assembly of cyclinD-CDK4 and -CDK6 complexes.